| Title | Profound muscle weakness and pain after one dose of actonel. | | Author(s) | Badayan I, Cudkowicz ME | | Institution | Neurology Clinical Trials Unit, Massachusetts General Hospital, Harvard Medical School, Charlestown, MA 02129, USA. | | Source | Case Report Med 2009.:693014. | | Abstract | The World Health Organization (WHO) defines osteopenia as a bone density between 1 and 2.5 standard deviation (SD) below the bone density of a normal young adult Iqbal 2000. Osteoporosis is defined as 2.5 SD or more below that reference point Iqbal 2000. Bisphosphonates are a group of medications used to treat osteoporosis, Padget's disease of bone, and osteopenia. We report a woman who developed profound muscle weakness and pain after one dose of Risedronate (Actonel). | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 19826634 |
|
